NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $215,282 | -3.5% | 2,935 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $223,000 | +8.8% | 2,935 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $205,000 | -93.3% | 2,946 | -78.6% | 0.00% | -90.0% |
| Q2 2021 | $3,048,000 | +67.8% | 13,741 | 0.0% | 0.01% | +66.7% |
| Q1 2021 | $1,816,000 | -23.6% | 13,741 | 0.0% | 0.01% | -33.3% |
| Q4 2020 | $2,378,000 | +259.2% | 13,741 | 0.0% | 0.01% | +80.0% |
| Q1 2019 | $662,000 | +43.9% | 13,741 | 0.0% | 0.01% | +400.0% |
| Q4 2018 | $460,000 | -36.1% | 13,741 | 0.0% | 0.00% | -75.0% |
| Q3 2018 | $720,000 | +67.4% | 13,741 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $430,000 | +43.3% | 13,741 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $300,000 | +7.9% | 13,741 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $278,000 | +1.8% | 13,741 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $273,000 | +14.7% | 13,741 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $238,000 | – | 13,741 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |